Books > Medicine > Other branches of medicine > Pharmacology
|
Buy Now
Accelerating the Development of New Drugs and Diagnostics - Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (Paperback, New)
Loot Price: R1,062
Discovery Miles 10 620
|
|
Accelerating the Development of New Drugs and Diagnostics - Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (Paperback, New)
Expected to ship within 12 - 17 working days
|
Advances in technologies and knowledge are creating new avenues for
research and opportunities for the discovery and clinical
development of innovative therapies and diagnostics. However,
despite these opportunities, only a small fraction of
investigational products are successfully developed into cures and
therapies that can be accessed by patients. One response to the
ever-widening gap between the number and promise of basic
scientific discoveries and the translation of those discoveries
into therapies is a renewed emphasis on collaborative approaches
among federal agencies, academia, and industry, all directed at the
advancement of the drug development enterprise. The newly developed
Cures Acceleration Network (CAN)-a part of the National Center for
Advancing Translational Sciences (NCATS) within the National
Institutes of Health (NIH)-has the potential to catalyze widespread
changes in NCATS, NIH, and the drug development ecosystem in
general. On June 4-5, 2012, the IOM Forum on Drug Discovery,
Development, and Translation held, at the request of NCATS, a
workshop-bringing together members of federal government agencies,
the private sector, academia, and advocacy groups-to explore
options and opportunities in the implementation of CAN.
Accelerating the Development of New Drugs and Diagnostics:
Maximizing the Impact of the Cures Acceleration Network: Workshop
Summary summarizes the workshop. Table of Contents Front Matter 1
Introduction 2 Approaches to Accelerating Translational Science 3
Application of Matching Authority 4 Application of Flexible
Research Authority 5 Situating CAN Within the Drug Development
Ecosystem 6 Final Reflections on Ways to Maximize the Goals of CAN
References Appendix A: Workshop Agenda Appendix B: Public Health
Service Act, Title IV - National Institutes of Health Appendix C:
Participant Biographies
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.